Latest Capital Raises News

Northern Minerals reports a robust Definitive Feasibility Study and secures conditional funding interest, positioning Browns Range as a critical supplier of heavy rare earths by 2028.

Basin Energy has acquired NeoDys Limited, gaining a substantial uranium and rare earth exploration package in Queensland, and launched a $1.25 million capital raise to fund maiden drilling in late 2025.

KALiNA Power advances its Alberta AI data centre power projects with a significant CAD 18 million transfer of assigned megawatts and engages bankers to fund development capital.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

NoviqTech Limited has launched Fuel Central for sustainable fuels traceability and established Quantum Intelligence Pty Ltd to advance quantum computing and AI applications, backed by a $1.08 million placement. The company also refreshed its board and expanded its international footprint.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Stakk Limited reports a staggering 1,836% year-on-year increase in quarterly receipts, positioning itself on track to hit an $8 million annual recurring revenue target by mid-2026.

Anson Resources has inked a key lithium supply deal with LG Energy Solution and made significant progress on its Green River Lithium Project in Utah, backed by a $5 million capital raise.

EMVision Medical Devices has successfully closed an oversubscribed Share Purchase Plan, raising $2 million and bringing total recent capital to $14 million. This funding positions the company to advance pivotal clinical trials and regulatory milestones for its innovative neurodiagnostic devices.